Subscribe to Newsletter

Discovery & Development

Discovery & Development Drug Discovery

APIs from the Algorithm

| Stephanie Vine | 2 min read

DRAGONFLY deep learning meets de novo drug design – and Roche has already tested the approach

Discovery & Development Drug Discovery

Combination Revelation

| Rob Coker | 2 min read

Could J&J’s combination treatment for PAH bridge the gaps between guidelines and practice, while easing the burden on patients?

Discovery & Development Clinical Trials

For Faster Trials, Improve Feasibility

| Christine Senn | 6 min read

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

Discovery & Development Clinical Trials

Regeneron on the Digital Age of Clinical Trials

| 6 min read

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Discovery & Development Formulation

MR Control

| Asma Patel, John McDermott | 4 min read

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path

Discovery & Development Drug Discovery

ADCs Versus Solid Tumors

| Stephanie Vine | 3 min read

Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

Discovery & Development Drug Discovery

Top Treatment Prospects: Alzheimer’s Disease

| Jamie Irvine | 9 min read

Experts discuss the most exciting Alzheimer’s Disease treatment trends – and make bold predictions for the future

Discovery & Development Ingredients

USP: A Mission Focused on Quality and Safety

| Chaitanya Koduri | 11 min read

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.

Discovery & Development Drug Discovery

Advancements in the Fight Against Alzheimer's Disease

| Mallikarjun Chityala | 3 min read

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Discovery & Development Formulation

Think Smaller: Interviewing Nanoform’s Edward Hæggström

| 5 min read

We ask about the story behind Nanoform and what nanotechnology could do for drug formulation.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine